Medicine and Dentistry
Assessment
100%
Levetiracetam
100%
Patient
76%
Paraneoplastic Cerebellar Degeneration
75%
Epileptic Seizure
66%
Brain Tumor
55%
Dystonia
50%
Opsoclonus Myoclonus Syndrome
50%
Surgery
33%
Neuro-Oncology
33%
Follow up
31%
Ductal Carcinoma
25%
Cerebrospinal Fluid Examination
25%
Oligoclonal Band
25%
Pleocytosis
25%
Prophylaxis
22%
Chemotherapeutic Agent
22%
Drug
22%
Side Effect
22%
Glioblastoma
19%
Neoplasm
19%
Disease Activity
14%
Prospective Study
11%
Somnolence
11%
Debulking
11%
Drug Therapy
11%
Perioperative Period
11%
Carbohydrate Mixture Plus Electrolytes
11%
Blood Toxicity
11%
Cognition
11%
Anticonvulsant
11%
Quality of Life
11%
Health
11%
Plasma
11%
Magnetic Resonance Imaging
9%
Nursing and Health Professions
Clinical Outcome
100%
Brain Ischemia
100%
Pilot Study
100%
Patient
66%
Time
66%
Monitoring
66%
A Wave
66%
Analyzer
33%
Kruskal Wallis Test
33%
Individualization
33%
National Institutes of Health Stroke Scale
33%
Cerebrovascular Accident
33%
Parameters
33%
Inpatient
33%
Symptom
33%
Sample
33%
Area under the Curve
33%